Global Short Bowel Syndrome Drugs Market 2019 - by Manufacturers, Regions, Type, Application, Sales, Revenue, and Forecast to 2025

  • In 2017, the global Short Bowel Syndrome Drugs market size was  million US$ and it is expected to reach  million US$ by the end of 2025, with a CAGR of  during 2018-2025.
    
    This report focuses on the global Short Bowel Syndrome Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Short Bowel Syndrome Drugs development in United States, Europe and China.
    
    The key players covered in this study
        Emmaus Medical
        Merck
        Shire
        Ardelyx
        Naia Pharmaceuticals
        Nutrinia
        OxThera
        GLyPharma Therapeutic
        Sancilio Pharmaceuticals
        Zealand Pharma
    
    Market segment by Type, the product can be split into
        Oral Route
        Parental Route
    
    Market segment by Application, split into
        Hospital Pharmacies
        Retail Pharmacies
        Online Pharmacies
    
    Market segment by Regions/Countries, this report covers
        United States
        Europe
        China
        Japan
        Southeast Asia
        India
        Central & South America
    
    The study objectives of this report are:
        To analyze global Short Bowel Syndrome Drugs status, future forecast, growth opportunity, key market and key players.
        To present the Short Bowel Syndrome Drugs development in United States, Europe and China.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by product type, market and key regions.
    
    In this study, the years considered to estimate the market size of Short Bowel Syndrome Drugs are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025
    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
  • 
    1 Report Overview
        1.1 Study Scope
        1.2 Key Market Segments
        1.3 Players Covered
        1.4 Market Analysis by Type
            1.4.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type (2013-2025)
            1.4.2 Oral Route
            1.4.3 Parental Route
        1.5 Market by Application
            1.5.1 Global Short Bowel Syndrome Drugs Market Share by Application (2013-2025)
            1.5.2 Hospital Pharmacies
            1.5.3 Retail Pharmacies
            1.5.4 Online Pharmacies
        1.6 Study Objectives
        1.7 Years Considered
    
    2 Global Growth Trends
        2.1 Short Bowel Syndrome Drugs Market Size
        2.2 Short Bowel Syndrome Drugs Growth Trends by Regions
            2.2.1 Short Bowel Syndrome Drugs Market Size by Regions (2013-2025)
            2.2.2 Short Bowel Syndrome Drugs Market Share by Regions (2013-2018)
        2.3 Industry Trends
            2.3.1 Market Top Trends
            2.3.2 Market Drivers
            2.3.3 Market Opportunities
    
    3 Market Share by Key Players
        3.1 Short Bowel Syndrome Drugs Market Size by Manufacturers
            3.1.1 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2013-2018)
            3.1.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2013-2018)
            3.1.3 Global Short Bowel Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
        3.2 Short Bowel Syndrome Drugs Key Players Head office and Area Served
        3.3 Key Players Short Bowel Syndrome Drugs Product/Solution/Service
        3.4 Date of Enter into Short Bowel Syndrome Drugs Market
        3.5 Mergers & Acquisitions, Expansion Plans
    
    4 Breakdown Data by Type and Application
        4.1 Global Short Bowel Syndrome Drugs Market Size by Type (2013-2018)
        4.2 Global Short Bowel Syndrome Drugs Market Size by Application (2013-2018)
    
    5 United States
        5.1 United States Short Bowel Syndrome Drugs Market Size (2013-2018)
        5.2 Short Bowel Syndrome Drugs Key Players in United States
        5.3 United States Short Bowel Syndrome Drugs Market Size by Type
        5.4 United States Short Bowel Syndrome Drugs Market Size by Application
    
    6 Europe
        6.1 Europe Short Bowel Syndrome Drugs Market Size (2013-2018)
        6.2 Short Bowel Syndrome Drugs Key Players in Europe
        6.3 Europe Short Bowel Syndrome Drugs Market Size by Type
        6.4 Europe Short Bowel Syndrome Drugs Market Size by Application
    
    7 China
        7.1 China Short Bowel Syndrome Drugs Market Size (2013-2018)
        7.2 Short Bowel Syndrome Drugs Key Players in China
        7.3 China Short Bowel Syndrome Drugs Market Size by Type
        7.4 China Short Bowel Syndrome Drugs Market Size by Application
    
    8 Japan
        8.1 Japan Short Bowel Syndrome Drugs Market Size (2013-2018)
        8.2 Short Bowel Syndrome Drugs Key Players in Japan
        8.3 Japan Short Bowel Syndrome Drugs Market Size by Type
        8.4 Japan Short Bowel Syndrome Drugs Market Size by Application
    
    9 Southeast Asia
        9.1 Southeast Asia Short Bowel Syndrome Drugs Market Size (2013-2018)
        9.2 Short Bowel Syndrome Drugs Key Players in Southeast Asia
        9.3 Southeast Asia Short Bowel Syndrome Drugs Market Size by Type
        9.4 Southeast Asia Short Bowel Syndrome Drugs Market Size by Application
    
    10 India
        10.1 India Short Bowel Syndrome Drugs Market Size (2013-2018)
        10.2 Short Bowel Syndrome Drugs Key Players in India
        10.3 India Short Bowel Syndrome Drugs Market Size by Type
        10.4 India Short Bowel Syndrome Drugs Market Size by Application
    
    11 Central & South America
        11.1 Central & South America Short Bowel Syndrome Drugs Market Size (2013-2018)
        11.2 Short Bowel Syndrome Drugs Key Players in Central & South America
        11.3 Central & South America Short Bowel Syndrome Drugs Market Size by Type
        11.4 Central & South America Short Bowel Syndrome Drugs Market Size by Application
    
    12 International Players Profiles
        12.1 Emmaus Medical
            12.1.1 Emmaus Medical Company Details
            12.1.2 Company Description and Business Overview
            12.1.3 Short Bowel Syndrome Drugs Introduction
            12.1.4 Emmaus Medical Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.1.5 Emmaus Medical Recent Development
        12.2 Merck
            12.2.1 Merck Company Details
            12.2.2 Company Description and Business Overview
            12.2.3 Short Bowel Syndrome Drugs Introduction
            12.2.4 Merck Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.2.5 Merck Recent Development
        12.3 Shire
            12.3.1 Shire Company Details
            12.3.2 Company Description and Business Overview
            12.3.3 Short Bowel Syndrome Drugs Introduction
            12.3.4 Shire Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.3.5 Shire Recent Development
        12.4 Ardelyx
            12.4.1 Ardelyx Company Details
            12.4.2 Company Description and Business Overview
            12.4.3 Short Bowel Syndrome Drugs Introduction
            12.4.4 Ardelyx Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.4.5 Ardelyx Recent Development
        12.5 Naia Pharmaceuticals
            12.5.1 Naia Pharmaceuticals Company Details
            12.5.2 Company Description and Business Overview
            12.5.3 Short Bowel Syndrome Drugs Introduction
            12.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.5.5 Naia Pharmaceuticals Recent Development
        12.6 Nutrinia
            12.6.1 Nutrinia Company Details
            12.6.2 Company Description and Business Overview
            12.6.3 Short Bowel Syndrome Drugs Introduction
            12.6.4 Nutrinia Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.6.5 Nutrinia Recent Development
        12.7 OxThera
            12.7.1 OxThera Company Details
            12.7.2 Company Description and Business Overview
            12.7.3 Short Bowel Syndrome Drugs Introduction
            12.7.4 OxThera Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.7.5 OxThera Recent Development
        12.8 GLyPharma Therapeutic
            12.8.1 GLyPharma Therapeutic Company Details
            12.8.2 Company Description and Business Overview
            12.8.3 Short Bowel Syndrome Drugs Introduction
            12.8.4 GLyPharma Therapeutic Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.8.5 GLyPharma Therapeutic Recent Development
        12.9 Sancilio Pharmaceuticals
            12.9.1 Sancilio Pharmaceuticals Company Details
            12.9.2 Company Description and Business Overview
            12.9.3 Short Bowel Syndrome Drugs Introduction
            12.9.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.9.5 Sancilio Pharmaceuticals Recent Development
        12.10 Zealand Pharma
            12.10.1 Zealand Pharma Company Details
            12.10.2 Company Description and Business Overview
            12.10.3 Short Bowel Syndrome Drugs Introduction
            12.10.4 Zealand Pharma Revenue in Short Bowel Syndrome Drugs Business (2013-2018)
            12.10.5 Zealand Pharma Recent Development
    
    13 Market Forecast 2018-2025
        13.1 Market Size Forecast by Regions
        13.2 United States
        13.3 Europe
        13.4 China
        13.5 Japan
        13.6 Southeast Asia
        13.7 India
        13.8 Central & South America
        13.9 Market Size Forecast by Product (2018-2025)
        13.10 Market Size Forecast by Application (2018-2025)
    
    14 Analyst's Viewpoints/Conclusions
    
    15 Appendix
        15.1 Research Methodology
            15.1.1 Methodology/Research Approach
                15.1.1.1 Research Programs/Design
                15.1.1.2 Market Size Estimation
                12.1.1.3 Market Breakdown and Data Triangulation
            15.1.2 Data Source
                15.1.2.1 Secondary Sources
                15.1.2.2 Primary Sources
        15.2 Disclaimer
        15.3 Author Details



    List of Tables and Figures
    
        Table Short Bowel Syndrome Drugs Key Market Segments
        Table Key Players Short Bowel Syndrome Drugs Covered
        Table Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)
        Figure Global Short Bowel Syndrome Drugs Market Size Market Share by Type 2013-2025
        Figure Oral Route Figures
        Table Key Players of Oral Route
        Figure Parental Route Figures
        Table Key Players of Parental Route
        Table Global Short Bowel Syndrome Drugs Market Size Growth by Application 2013-2025 (Million US$)
        Figure Hospital Pharmacies Case Studies
        Figure Retail Pharmacies Case Studies
        Figure Online Pharmacies Case Studies
        Figure Short Bowel Syndrome Drugs Report Years Considered
        Table Global Short Bowel Syndrome Drugs Market Size 2013-2025 (Million US$)
        Figure Global Short Bowel Syndrome Drugs Market Size and Growth Rate 2013-2025 (Million US$)
        Table Global Short Bowel Syndrome Drugs Market Size by Regions 2013-2025 (Million US$)
        Table Global Short Bowel Syndrome Drugs Market Size by Regions 2013-2018 (Million US$)
        Table Global Short Bowel Syndrome Drugs Market Share by Regions 2013-2018
        Figure Global Short Bowel Syndrome Drugs Market Share by Regions 2013-2018
        Figure Global Short Bowel Syndrome Drugs Market Share by Regions 2018
        Table Market Top Trends
        Table Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2013-2018) (Million US$)
        Table Global Short Bowel Syndrome Drugs Market Share by Manufacturers (2013-2018)
        Figure Global Short Bowel Syndrome Drugs Market Share by Manufacturers in 2018
        Table Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
        Table Key Players Head office and Area Served
        Table Key Players Short Bowel Syndrome Drugs Product/Solution/Service
        Table Date of Enter into Short Bowel Syndrome Drugs Market
        Table Mergers & Acquisitions, Expansion Plans
        Table Global Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Global Short Bowel Syndrome Drugs Market Size Share by Type (2013-2018)
        Figure Global Short Bowel Syndrome Drugs Market Size Market Share by Type (2013-2018)
        Table Global Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Global Short Bowel Syndrome Drugs Market Size Share by Application (2013-2018)
        Figure Global Short Bowel Syndrome Drugs Market Size Market Share by Application (2013-2018)
        Figure Global Short Bowel Syndrome Drugs Revenue Market Share by Application in 2017
        Figure United States Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table United States Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table United States Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table United States Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table United States Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table United States Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table United States Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Figure Europe Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table Europe Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table Europe Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table Europe Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Europe Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table Europe Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Europe Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Figure China Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table China Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table China Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table China Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table China Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table China Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table China Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Figure Japan Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table Japan Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table Japan Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table Japan Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Japan Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table Japan Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Japan Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Figure Southeast Asia Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table Southeast Asia Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table Southeast Asia Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table Southeast Asia Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Southeast Asia Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table Southeast Asia Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Southeast Asia Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Figure India Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table India Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table India Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table India Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table India Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table India Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table India Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Figure Central & South America Short Bowel Syndrome Drugs Market Size 2013-2018 (Million US$)
        Table Central & South America Key Players Short Bowel Syndrome Drugs Revenue (2017-2018) (Million US$)
        Table Central & South America Key Players Short Bowel Syndrome Drugs Market Share (2017-2018)
        Table Central & South America Short Bowel Syndrome Drugs Market Size by Type (2013-2018) (Million US$)
        Table Central & South America Short Bowel Syndrome Drugs Market Share by Type (2013-2018)
        Table Central & South America Short Bowel Syndrome Drugs Market Size by Application (2013-2018) (Million US$)
        Table Central & South America Short Bowel Syndrome Drugs Market Share by Application (2013-2018)
        Table Emmaus Medical Company Details
        Table Emmaus Medical Revenue in Short Bowel Syndrome Drugs Business (2013-2018) (Million US$)
        Figure Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Emmaus Medical Recent Development
        Table Merck Company Details
        Table Merck Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Merck Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Merck Recent Development
        Table Shire Company Details
        Table Shire Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Shire Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Shire Recent Development
        Table Ardelyx Company Details
        Table Ardelyx Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Ardelyx Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Ardelyx Recent Development
        Table Naia Pharmaceuticals Company Details
        Table Naia Pharmaceuticals Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Naia Pharmaceuticals Recent Development
        Table Nutrinia Company Details
        Table Nutrinia Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Nutrinia Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Nutrinia Recent Development
        Table OxThera Company Details
        Table OxThera Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure OxThera Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table OxThera Recent Development
        Table GLyPharma Therapeutic Company Details
        Table GLyPharma Therapeutic Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure GLyPharma Therapeutic Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table GLyPharma Therapeutic Recent Development
        Table Sancilio Pharmaceuticals Company Details
        Table Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Sancilio Pharmaceuticals Recent Development
        Table Zealand Pharma Company Details
        Table Zealand Pharma Revenue in Short Bowel Syndrome Drugs Business (2013-2018)(Million US$)
        Figure Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome Drugs Business (2013-2018)
        Table Zealand Pharma Recent Development
        Table Global Short Bowel Syndrome Drugs Market Size by Regions (Million US$) 2018-2025
        Figure Global Short Bowel Syndrome Drugs Market Size Share by Regions (2018-2025)
        Figure Global Short Bowel Syndrome Drugs Market Size Share by Regions in 2025
        Figure United States Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Europe Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure China Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Japan Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Southeast Asia Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure India Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Figure Central & South America Short Bowel Syndrome Drugs Market Size Forecast (2018-2025)(Million USD)
        Table Global Short Bowel Syndrome Drugs Market Size by Product (2018-2025) (Million US$)
        Figure Global Short Bowel Syndrome Drugs Market Size by Product (2018-2025)
        Figure Global Short Bowel Syndrome Drugs Market Size by Product in 2025
        Table Global Short Bowel Syndrome Drugs Market Size by Application (2018-2025) (Million US$)
        Figure Global Short Bowel Syndrome Drugs Market Size by Application (2018-2025)
        Figure Global Short Bowel Syndrome Drugs Market Size by Application in 2025
        Table Research Programs/Design for This Report
        Figure Bottom-up and Top-down Approaches for This Report
        Figure Data Triangulation
        Table Key Data Information from Secondary Sources
        Table Key Data Information from Primary Sources